We identified intermittent gait disturbance (IGD) observed in the mild stage of idiopathic normal pressure hydrocephalus (iNPH). The first purpose of this study was to clarify the temporal gait profile of IGD during long-distance gait. The second purpose was to confirm the difference in treatment effect after cerebrospinal fluid (CSF) shunting in patients with and without IGD.
| INTRODUCTION
Gait disturbances in idiopathic normal pressure hydrocephalus (iNPH) have been historically characterized by a persistent broad-based, short-stepped "magnetic" gait. [1] [2] [3] [4] However, the precise temporal nature of long-distance gait has not been accurately described. We have recently identified an intermittent type of gait disturbance (IGD) in iNPH patients using the 6-minute walk test (6MWT). 5 This pattern was particularly seen in mild and early stages of iNPH and seemed to be related to falls. Typically, patients complain about falling, but do not mention deterioration of gait after a walking load. Furthermore, IGD is difficult to identify in the examination room, because it is not apparent in short-distance walking. Gait disorders in iNPH are usually considered to be a persistent, not transient deficit. Perhaps for this reason, evaluation of gait function included only used shortdistance gait testing, such as the TUG, 2,6 the 10-to 25-meter walk test, [7] [8] [9] or other gait scoring systems that employ short-distance gait measures. 10, 11 The 6MWT is widely used as gait loading test; reliability and validity of the 6MWT have been established as a tool to evaluate walking endurance for the heart and lung diseases. 5 However, 6MWT has not been applied to evaluate gait performance of iNPH patients. The purposes of this study were to clarify the temporal gait profile of IGD during long-distance gait and to confirm the difference in treatment effect after cerebrospinal fluid (CSF) shunting in patients with and without IGD. A discussion of the pathophysiological mechanisms of IGD in iNPH and the implications of IGD as an early diagnostic marker of iNPH are presented.
| MATERIALS AND METHODS

| Patients
Fourteen iNPH patients (11 men, 3 women, mean age 75.6 ± 4.1) with mild gait disturbance, which was defined as a timed 3-meter upand-go test (TUG) of 20 seconds or less, were included in this study. Exclusion criteria included any neurological, orthopedic, or internal organ disorders influencing gait. Exclusion criteria also included neurogenic intermittent claudication (IC) and vascular IC, which may present intermittent gait disturbance.
A questionnaire was answered by all patients using the interrogative: "Do you experience gait difficulty after over five minutes of walking?" Based on this response, seven patients who answered "yes"
formed the IGD group, and seven patients who answered "no" formed the persistent gait disturbance (PGD) group. 16 and Frontal Assessment Battery (FAB). 17 
| Pre-and post-shunt gait assessment
The TUG was consecutively performed three times over a period of 3 minutes, and average times were calculated. The 6MWT was performed according to the standardized protocol of the American thoracic society. 5 Prior to starting the 6MWT, patients were at rest in the sitting position for at least 10 minutes. The total gait distance and gait performances, including parameters of cadence, step length, and gait speed at 60-second intervals, were measured during the 6MWT. Pulse rate was continuously monitored using a pulse oximeter throughout the 6MWT. Walking effort was evaluated based on the degree of increase in pulse rate.
To eliminate the potential influence of footwear in the overall time of the TUG and 6MWT, 18 all tests were performed using sneaker type footwear. For patients judged to be at risk of falling, an examiner followed all subjects at one-step behind each patient to prevent falling without interfering with their walking pace.
| Evaluation of iNPH symptom improvement 3 months after surgery
Prior to surgery and 3 months after surgery, gait, cognitive, and urinary disturbance were evaluated by iNPH Grading Scale (iNPHGS) 10 The treatment effect of CSF shunting was evaluated by iNPHGS. In the IGD group, the presence of IGD was evaluated by physician interview at 3 months after surgery.
| Statistical analysis
The Wilcoxon signed-rank test was conducted to measure differences between the pre-OP and post-OP results of the TUG and the total distance of the 6MWT. Analysis of step length, cadence, and pulse recordings during the 6MWT was conducted using twoway repeated measures ANOVA with two factors as time periods
(1-min serration) between the pre-OP and post-OP periods for each group. The chronological changes of these gait factors in the 6MWT were also analyzed by two-way repeated measures ANOVA compared with the first one minute. The alpha level was set at 0.05. Data were presented as the mean ± standard deviation of the mean.
| Ethics statement
The study protocol was approved by the ethics committee at the Osaka Medical College (No. 1555), and written informed consent was obtained from all patients or their caregivers. The study was carried out according to the Declaration of Helsinki.
| RESULTS
There were no significant differences in demographic data between the two groups (Tables 1and 2) . LP, lumboperitoneal shunt; VP, ventriculoperitoneal shunt; MMSE, mini-mental state examination; FAB, frontal assessment battery; iNPHGS, iNPH grading scale; G, gait; C, cognitive; U, urinary.
T A B L E 1 Characteristics of the IGD patients
| Gait analysis of the IGD group by the 6MWT
In the IGD group, preoperatively all patients exhibited gradual aggravation of gait with increased walking time, and all gait parameters, including step length, cadence, and velocity, changed proportionally with gait loading ( Figure 1A -C).
Step length and walking speed decreased significantly after three minutes, and cadence also increased significantly after three minutes compared with the initial 1-min recording. None of the patients complained of either hip or leg pain during the 6MWT. Propulsive gait was not observed in the beginning of the 6MWT before shunt surgery in all patients (Movie S1); however,
propulsive gait was found in the latter half of the 6MWT before shunt surgery in four patients of IGD group (Movie S2). The gait disturbance that appeared in the second half of the 6MWT recovered after a few minutes break.
The preoperative parameters of shortened step length, increased cadence, and reduced gait velocity after 3 minutes of gait loading observed in the IGD group significantly improved post-operatively ( Figure 1A-C) . Consequently, the preoperative total walking distance of 236.5 ± 34.2 m was significantly lengthened to 305.1 ± 29.6 m after CSF shunting (P = .018; Figure 3A ).
| Gait analysis of the PGD group by the 6MWT
In the PGD group, preoperatively all patients showed no significant aggravation of gait during gait loading (Figure 2A-C) . Furthermore, no significant improvements were observed in step length, cadence, and velocity after CSF shunting (Figure 2A-C) . However, total distance of the 6MWT in preoperative test was slightly elongated compared with that in post-operative PGD test (PGD: pre-OP = 319.6 ± 20.6 m vs post-OP = 327.4 ± 22.0 m, P = .063; Figure 3C ).
| Gait analysis by the TUG
There were no significant differences between the pre-and post-operative 
| Pulse rate changes during the 6MWT
There were no significant changes in pulse rate observed during the pre-and post-operative 6MWT both in the IGD and PGD group F I G U R E 1 Averaged step length (A), cadence (B), and velocity (C) per minute for the 6MWT in the IGD group. Preoperative gait parameters with gait loading significantly improved postoperatively. Asterisks indicate significant changes as compared with preoperative 6MWT (P < .05). There were no significant differences in pulse rate between the preoperative and postoperative 6MWT (D). IGD, intermittent gait disturbance; 6MWT, 6-min walk test F I G U R E 2 Averaged step length (A), cadence (B), and velocity (C) per minute for the 6MWT in the PGD group. Preoperative gait parameters with gait loading did not improve post-operatively. There were no significant differences in pulse rate between the preoperative and post-operative 6MWT (D). PGD, persistent gait disturbance; 6MWT, 6-min walk test ( Figures 1C and 2C) . Therefore, pre-and post-operative walking efforts were determined to be unchanged.
| Symptomatic recovery 3 months after CSF shunting
In all cases, except for the IGD case 2, iNPHGS showed improvement of 1 or more (Tables 1and 2) . After CSF shunting, the symptom of IGD rapidly disappeared in all cases, including case 2.
| DISCUSSION
| Intermittent gait disturbance: A common but hidden symptom at the mild stage of iNPH
This is the first report to describe a pattern of intermittent gait disturbance (IGD) in the mild stage of iNPH. Extended distance walking tests using the 6MWT showed that gait disturbance worsened proportionally with gait loading. The main characteristic of IGD is a progressive pattern of decreased gait speed and step length with increased cadence and absence of leg pain. Although the step width has not been evaluated in this study, the video movie shows that another characteristic of IGD is that it does not involve wide base in IGD. The reason why the step width is not wide may be related to the fact that the gait disturbance is in the mild stage. The fact that no difference in pulse rate was observed before and after shunting suggested that fatigue may not be a causative factor in IGD associated with iNPH.
Gait difficulty is a well-known core symptom in iNPH patients and is typically characterized by signs of reduced gait velocity, diminished stride length, and reduced floor-to-floor clearance. Currently, all these signs have been shown to improve after treatment with CSF shunting. 2, 4, 19, 20 However, to date, the temporal nature of gait disturbance during long-distance gait in iNPH has not been accurately described.
In contrast, we have shown that the TUG was not able to detect significant improvements in gait following CSF shunting in iNPH patients, especially with regard to the subtle features of IGD, while results using the 6MWT clearly demonstrated improvements after shunting.
The reason that TUG is invalid in the detection of IGD is that although TUG is a complicated task including muscular strength and balance such as turning, standing, and sitting, there is no aspect of walking load at all. Therefore, we postulate that the reason why IGD has not been previously recognized as a clinical feature of iNPH is that testing has focused on observation and evaluation of short distant gait only.
In our study, 50% of the patients diagnosed with mild iNPH presenting with a TUG of <20 seconds showed signs of IGD. Therefore, although the sample size was too small, our findings suggest the possibility that IGD may be a common finding in the early stage of iNPH. IGD may be a preclinical or hidden feature in iNPH, and this suggests the potential usefulness of IGD as a diagnostic tool for early diagnosis of iNPH.
Further studies may more accurately identify the role of IGD in iNPH and may reveal a spectrum of gait disorders in iNPH, presumably with onset of initially intermittent gait dysfunction followed by progression to a complete persistent gait disturbance.
In the PGD group, improvement in walking function could not be detected with TUG and 6MWT before and after surgery. However, the fact that iNPHGS improved in all cases of PGD group at 3 months after shunt surgery means that all patients in the PGD group are definite iNPH in Japan guidelines. 12 This discrepancy is thought to arise from postoperative evaluation being performed only 7 days after surgery. Seven days after surgery, it seems that the symptomatic improvement process is still in progress and the influence of surgical invasion and perioperative exercise restriction remains. On the contrary, despite such non-optimal conditions, improvement of IGD at 6MWT indicates that IGD is a highly reversible symptom expected to be improved by shunt surgery.
| Intermittent gait disturbance and intermittent claudication
Longer distance gait testing using the 6MWT revealed the subtle features of gait in IGD, which included decreases in gait speed and step length with increases in cadence proportional to gait distance. These features resemble well-known forms of intermittent claudication (IC), such as vascular IC (VIC) and neurogenic IC (NIC). VIC is typically caused by
The total walking distance (A) for the 6MWT in the IGD group was significantly lengthened post-operatively (P = .018). Asterisks indicate significant changes as compared with preoperative 6MWT (P < .05). There was no significant difference between the preoperative and post-operative TUG in the IGD group (B). In the PGD group, no significant difference between the preoperation and post-operation was observed not only at TUG (d) but also at 6MWT (C). 6MWT, 6-min walk test; TUG, timed 3-m up-and-go test; CSF, cerebrospinal fluid obstructive atherosclerosis and involves both decreases in step length and gait speed due to accompanying lower limb weakness or pain. 21, 22 In contrast, NIC is usually caused by spinal stenotic nerve root compression and is also associated with decreases in step length and gait speed with progressive radiating lower limb pain after sustained gait. 23, 24 However, there are potentially three major differences between the features of IGD and the classical types of IC. First, in contrast to VIC and NIC, IGD in iNPH does not seem to be associated with either lower limb pain or weakness induced by ambulatory loading. Second, cadence was shown to gradually increase in IGD, while cadence is reported to decrease in VIC and NIC because of leg pain or weakness. 21, 23 We believe the increasing cadence observed in IGD is a compensatory mechanism for decreases in gait speed and shortening of step length.
Third, IGD in iNPH is frequently associated with balance disturbances, such as propulsive gait, which increases the inherent risks of falling.
These potential differences between IGD and IC are summarized in Table 3 . However, as there is a fundamental common point that it develops gait disturbance accompanying walking load and is reversible, IGD may be termed hydrocephalic IC as a new category of IC.
| Ischemic mechanism in early stage of iNPH
Gait difficulty in VIC and NIC is thought to be related to progressive ischemia of muscles and nerves with walking load. 25, 26 Because both IGD and other types of IC have a progressive onset, it is possible that ischemia is also involved in the pathogenic mechanism of IGD.
Although the exact ischemic pathophysiological mechanisms underlying gait disturbances in iNPH are still controversial, a model of vascular compression and successive decrease in cerebral blood flow (CBF) has been proposed by Batman et al 27 Another research has been directed at investigating the nature of decreased CBF in the frontal lobe and periventricular white matter. 8, 28, 29 Our results tend to support an ischemic mechanism for the onset of symptoms in iNPH patients in the early stage because of the short temporal relationship of symptoms with progressive gait loading. 
| Intermittent gait disturbance as a mild and early sign of iNPH
| Keys for recognizing intermittent gait disturbance
An important key for recognizing IGD is appropriate early patient questioning especially in the outpatient setting, when the subtle early signs of gait disturbance induced by gait loading first appear. These early signs may go unnoticed by the patient or primary care physician or may be masked by presentation as falls and can only be uncovered and clarified by detailed direct questioning such as "Do you experience gait difficulty after over five minutes of walking?" In addition, when considering the indications for shunting in iNPH patients with mild symptoms, we have recommended long-distance gait testing as an adjunct to standard guideline testing of gait function.
| CONCLUSIONS
Intermittent gait disturbance (IGD) is a novel and previously unnoticed feature of mild iNPH. IGD is characterized by a decrease in step length and gait speed and by an increase in cadence without leg pain after gait load. Long-distance walking tests, such as 6MWT, and asking questions focusing on IGD in falling elderly patients may lead to identification of IGD. Further studies on IGD may lead to earlier diagnosis of iNPH with possible improved surgical outcomes.
